GlassScriptPhysician profile
Kent G Farish
NPI 1831176601
$740.64
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $102 · 2021: $390 · 2022: $194 · 2023: $54.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $94.10 | 2020-2022 | |
| Abbvie INC. | $93.26 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $79.43 | 2021-2022 | |
| Global Blood Therapeutics, INC. | $76.03 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.14 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $35.52 | 2021 | |
| Exact Sciences Corporation | $35.34 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $34.01 | 2022 | |
| Lilly USA, LLC | $29.24 | 2020-2021 | |
| Dexcom, INC. | $21.16 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $20.13 | 2021 | |
| Boston Scientific Corporation | $19.84 | 2021 | |
| Abbott Laboratories | $19.78 | 2022 | |
| Antares Pharma, INC. | $19.66 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.27 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $18.96 | 2023 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $18.53 | 2020 | |
| Pfizer INC. | $17.62 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.66 | 2021 | |
| Medline Industries LP | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Farish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.